|
1
|
Hartgrink HH, Jansen EP, van Grieken NC
and van de Velde CJ: Gastric cancer. Lancet. 374:477–490. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sim F and Mckee M: Issues in Public
Health. Open University Press; 2011, View Article : Google Scholar
|
|
3
|
World Health Organization: World Cancer
Report. 2014.
|
|
4
|
Chang AH and Parsonnet J: Role of bacteria
in oncogenesis. Clin Microbiol Rev. 23:837–857. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Choi YY, An JY, Kim HI, Cheong JH, Hyung
WJ and Noh SH: Current practice of gastric cancer treatment. Chin
Med J. 127:547–553. 2014.PubMed/NCBI
|
|
6
|
Raymond W and Ruddon RW: Cancer Biology.
4th. Oxford University Press; Oxford: pp. 7912007
|
|
7
|
Orditura M, Galizia G, Sforza V,
Gambardella V, Fabozzi A, Laterza MM, Andreozzi F, Ventriglia J,
Savastano B, Mabilia A, et al: Treatment of gastric cancer. World J
Gastroenterol. 20:1635–1649. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jian-bo X, Hui W, Yu-long H, Chang-hua Z,
Long-juan Z, Shi-rong C and Wen-hua Z: Astrocyte-elevated gene-1
overexpression is associated with poor prognosis in gastric cancer.
Med Oncol. 28:455–462. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liang L, Li L, Tian J, Lee SO, Dang Q,
Huang CK, Yeh S, Erturk E, Bushinsky D, Chang LS, et al: Androgen
receptor enhances kidney stone-CaOx crystal formation via
modulation of oxalate biosynthesis & oxidative stress. Mol
Endocrinol. 28:1291–1303. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gomez-Martin C, Plaza JC, Pazo-Cid R,
Salud A, Pons F, Fonseca P, Leon A, Alsina M, Visa L, Rivera F, et
al: Level of HER2 gene amplification predicts response and
overall survival in HER2-positive advanced gastric cancer treated
with trastuzumab. J Clin Oncol. 31:4445–4452. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang DD, Chen YB, Pan K, Wang W, Chen SP,
Chen JG, Zhao JJ, Lv L, Pan QZ, Li YQ, et al: Decreased expression
of the ARID1A gene is associated with poor prognosis in
primary gastric cancer. PLoS One. 7:e403642012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yan HB, Wang XF, Zhang Q, Tang ZQ, Jiang
YH, Fan HZ, Sun YH, Yang PY and Liu F: Reduced expression of the
chromatin remodeling gene ARID1A enhances gastric cancer
cell migration and invasion via downregulation of E-cadherin
transcription. Carcinogenesis. 35:867–876. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Okugawa Y, Tanaka K, Inoue Y, Kawamura M,
Kawamoto A, Hiro J, Saigusa S, Toiyama Y, Ohi M, Uchida K, et al:
Brain-derived neurotrophic factor/tropomyosin-related kinase B
pathway in gastric cancer. Br J Cancer. 108:121–130. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Santoro R, Carboni F, Lepiane P, Ettorre
GM and Santoro E: Clinicopathological features and prognosis of
gastric cancer in young European adults. Br J Surg. 94:737–742.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shimada H, Noie T, Ohashi M, Oba K and
Takahashi Y: Clinical significance of serum tumor markers for
gastric cancer: A systematic review of literature by the Task Force
of the Japanese Gastric Cancer Association. Gastric Cancer.
17:26–33. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang S, Yee C, Ching T, Yu H and Garmire
LX: A novel model to combine clinical and pathway-based
transcriptomic information for the prognosis prediction of breast
cancer. PLoS Comput Biol. 10:e10038512014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huang S, Chong N, Lewis NE, Jia W, Xie G
and Garmire LX: Novel personalized pathway-based metabolomics
models reveal key metabolic pathways for breast cancer diagnosis.
Genome Med. 8:342016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cristescu R, Lee J, Nebozhyn M, Kim KM,
Ting JC, Wong SS, Liu J, Yue YG, Wang J, Yu K, et al: Molecular
analysis of gastric cancer identifies subtypes associated with
distinct clinical outcomes. Nat Med. 21:449–456. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Woo HG, Park ES, Cheon JH, Kim JH, Lee JS,
Park BJ, Kim W, Park SC, Chung YJ, Kim BG, et al: Gene
expression-based recurrence prediction of hepatitis B virus-related
human hepatocellular carcinoma. Clin Cancer Res. 14:2056–2064.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Irizarry RA, Bolstad BM, Collin F, Cope
LM, Hobbs B and Speed TP: Summaries of Affymetrix GeneChip probe
level data. Nucleic Acids Res. 31:e152003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
R Core Team: R: A language and environment
for statistical computing. Vienna, Austria: The R Foundation for
Statistical Computing. http://www.R-project.org/2017.
|
|
22
|
Kruschke JK: Bayesian estimation
supersedes the t test. J Exp Psychol Gen. 142:573–603. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nagarajan N and Keich U: Reliability and
efficiency of algorithms for computing the significance of the
Mann-Whitney test. Comput Stat. 24:6052009. View Article : Google Scholar
|
|
24
|
Therneau T: A package for survival
analysis in S. R package version. 2:37. 2014.
|
|
25
|
Farinelli A, Bicego M, Bistaffa F and
Ramchurn SD: A hierarchical clustering approach to large-scale
near-optimal coalition formation with quality guarantees. Eng Appl
Art Intell. 59:170–185. 2017. View Article : Google Scholar
|
|
26
|
Kolde R: Pheatmap: Pretty Heatmaps
[Software]. 2015.
|
|
27
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:pp. 15545–15550. 2005;
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Drier Y, Sheffer M and Domany E:
Pathway-based personalized analysis of cancer. Proc Natl Acad Sci
USA. 110:pp. 6388–6393. 2013; View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Goeman JJ: L1 penalized estimation in the
Cox proportional hazards model. Biom J. 52:70–84. 2010.PubMed/NCBI
|
|
30
|
Bachoc F: Cross validation and maximum
likelihood estimations of hyper-parameters of Gaussian processes
with model misspecification. Comput Stat Data Anal. 66:55–69. 2013.
View Article : Google Scholar
|
|
31
|
Yoo NJ, Lee JW, Kim YJ, Soung YH, Kim SY,
Nam SW, Park WS, Lee JY and Lee SH: Loss of caspase-2, −6 and −7
expression in gastric cancers. APMIS. 112:330–335. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang MY, Zhu ML, He J, Shi TY, Li QX, Wang
YN, Li J, Zhou XY, Sun MH, Wang XF, et al: Potentially functional
polymorphisms in the CASP7 gene contribute to gastric
adenocarcinoma susceptibility in an eastern Chinese population.
PLoS One. 8:e740412013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhou J, Chen GB, Tang YC, Sinha RA, Wu Y,
Yap CS, Wang G, Hu J, Xia X, Tan P, et al: Genetic and
bioinformatic analyses of the expression and function of PI3K
regulatory subunit PIK3R3 in an Asian patient gastric cancer
library. BMC Med Genomics. 5:342012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fang WL, Huang KH, Lan YT, Lin CH, Chang
SC, Chen MH, Chao Y, Lin WC, Lo SS, Li AF, et al: Mutations in
PI3K/AKT pathway genes and amplifications of PIK3CA are associated
with patterns of recurrence in gastric cancers. Oncotarget.
7:6201–6220. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Matsuoka T and Yashiro M: The role of
PI3K/Akt/mTOR signaling in gastric carcinoma. Cancers. 6:1441–1463.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Konturek PC, Kania J, Kukharsky V, Raithel
M, Ocker M, Rembiasz K, Hahn EG and Konturek SJ: Implication of
peroxisome proliferator-activated receptor gamma and
proinflammatory cytokines in gastric carcinogenesis: Link to
Helicobacter pylori-infection. J Pharmacol Sci. 96:134–143. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Konturek PC, Kania J, Konturek JW,
Nikiforuk A, Konturek SJ and Hahn EG: H. pylori infection, atrophic
gastritis, cytokines, gastrin, COX-2, PPAR gamma and impaired
apoptosis in gastric carcinogenesis. Med Sci Monit. 9:SR53–SR66.
2003.PubMed/NCBI
|
|
38
|
Guo F, Ren X, Dong Y, Hu X, Xu D, Zhou H,
Meng F, Tian W and Zhao Y: Constitutive expression of PPARγ
inhibits proliferation and migration of gastric cancer cells and
down-regulates Wnt/β-Catenin signaling pathway downstream target
genes TERT and ENAH. Gene. 584:31–37. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang P, Wang YC, Chen XY, Shen ZY, Cao H,
Zhang YJ, Yu J, Zhu JD, Lu YY and Fang JY: CTHRC1 is
upregulated by promoter demethylation and transforming growth
factor-β1 and may be associated with metastasis in human gastric
cancer. Cancer Sci. 103:1327–1333. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yu J, Feng J, Zhi X, Tang J, Li Z, Xu Y,
Yang L, Hu Z and Xu Z: Let-7b inhibits cell proliferation,
migration, and invasion through targeting Cthrc1 in gastric cancer.
Tumour Biol. 36:3221–3229. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gu L, Liu L, Zhong L, Bai Y, Sui H, Wei X,
Zhang W, Huang P, Gao D, Kong Y and Lou G: Cthrc1 overexpression is
an independent prognostic marker in gastric cancer. Hum Pathol.
45:1031–1038. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ji YB, Qu ZY and Zou X: Juglone-induced
apoptosis in human gastric cancer SGC-7901 cells via the
mitochondrial pathway. Exp Toxicol Pathol. 63:69–78. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang H, Fang DC, Lan CH and Luo YH:
Helicobacter pylori infection induces apoptosis in gastric
cancer cells through the mitochondrial pathway. J Gastroenterol
Hepatol. 22:1051–1056. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yu RX, Hu XM, Xu SQ, Jiang ZJ and Yang W:
Effects of fucoxanthin on proliferation and apoptosis in human
gastric adenocarcinoma MGC-803 cells via JAK/STAT signal pathway.
Eur J Pharmacol. 657:10–19. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Shigeyasu K, Nagasaka T, Mori Y, Yokomichi
N, Kawai T, Fuji T, Kimura K, Umeda Y, Kagawa S, Goel A and
Fujiwara T: Clinical significance of MLH1 methylation and CpG
island methylator phenotype as prognostic markers in patients with
gastric cancer. PLoS One. 10:e01304092015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Li Y, Yang Y, Lu Y, Herman JG, Brock MV,
Zhao P and Guo M: Predictive value of CHFR and MLH1 methylation in
human gastric cancer. Gastric Cancer. 18:280–287. 2015. View Article : Google Scholar : PubMed/NCBI
|
